Le Lézard
Classified in: Transportation, Health, Science and technology, Business
Subjects: CON, TRI

Greenphire Partners with Lyft to Support Clinical Trial Patient Retention and Access


KING OF PRUSSIA, Pa., June 19, 2018 /PRNewswire/ -- Greenphire, the global leader in financial software for clinical trials, today announced it has partnered with Lyft, to deliver a seamless experience for site coordinators to book a ride and execute a reimbursement or stipend for clinical trial participants within its industry-leading ClinCard solution. With this integration, the clinical research community will have one seamless application to eliminate both the financial and logistical hurdles that impact clinical trial retention.

"Expense management and ground transportation are critical to participant retention. However, patient and site needs are not equal. That is why we have designed the only application that allows a study coordinator to order a car, reimburse for a ride, and provide a stipend all within one software," said Jim Murphy, CEO, Greenphire.

Greenphire's ClinCard is the industry standard in participant payment automation, facilitating more than six million reimbursements to over one million clinical trial participants around the world. The new offering is the only solution that brings both ride and payment automation within one central application, delivering a better experience for both sites and participants.

"Lyft is committed to improving accessibility for patients in need of better transportation options," said Gyre Renwick, Vice President of Lyft Business. "This opportunity to extend our services with Greenphire allows us to work together to create the best experience for clinical trial participants and help to eliminate any complications for patients getting to and from their appointments."

Centralizing the participant retention budget within ClinCard eliminates siloes and optimizes financial visibility and predictability for sponsors. It also allows sponsors to make clinical trial participation easier for patients, without adding an administrative burden for site coordinators.

About Greenphire
Greenphire is the global leader in clinical trial payment software. Greenphire is exclusively focused on optimizing clinical trial performance by streamlining payment processes from sponsors and CROs to sites and patients. The choice of industry leaders worldwide, Greenphire supports site centricity and sustainability, increases patient engagement and retention, and provides more comprehensive financial data, resulting in better trials. Learn more at www.greenphire.com.

Media Contact:
Kathleen Fusco
(267) 828-4862
[email protected]

 

SOURCE Greenphire


These press releases may also interest you

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...

at 18:18
Targeting a Solution is an insightful and impactful fireside discussion dedicated to ending Veteran suicide that will have its next iteration on April 20th, 2024, in Kannapolis, NC hosted by The Independence Fund. The panel will feature four-term...



News published on and distributed by: